BNT162b2 Omicron (KP.2)

DB19415

biotech approved

Deskripsi

BNT162b2 Omicron (KP.2) is COVID-19 mRNA vaccine encoding the viral spike (S) glycoprotein of SARS-CoV-2 Omicron variant lineage KP.2. It is the active ingredient in the 2024-2025 formulation of Pfizer-BioNTech's Comirnaty vaccine.L36030

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Contoh Produk & Brand

Produk: 4 • International brands: 0
Produk
  • Comirnaty
    Injection, suspension • 0.048 mg/0.48mL • Intramuscular • US • Approved
  • Comirnaty
    Injection, suspension • 0.042 mg/0.418mL • Intramuscular • US • Approved
  • Pfizer-BioNTech Covid-19 Vaccine
    Injection, suspension • 0.0158 mg/1.58mL • Intramuscular • US
  • Pfizer-BioNTech Covid-19 Vaccine
    Injection, suspension • 0.0158 mg/0.48mL • Intramuscular • US

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul